Snowball logo
logo
SCTX

Scribe Therapeutics Inc. Common Stock

SCTX • NASDAQ
$15.60+$0.195  (1.27%)
💡 Click on a row in the table to make it appear on the graph
📊 Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20242025TTM
Revenue
Total revenue
27.4151.1726.17
COGS
---
Gross Profit
---
Operating Expenses & Income
Operating Income
(42.83)(26.07)(39.01)
Total Operating Expenses
70.2477.2465.18
R&D Expenses
57.0860.850
Selling General & Admin Expenses
13.1616.4515.18
Earnings from Continuing Operations
Interest Expense
(2.381)(2.393)(2.07)
Interest Income
6.1543.3262.841
Income Tax Expense
---
Net Income
Net Income
(47.79)(21.81)(37.15)
Supplemental
EBIT
---
EBITDA
---
In millions of USD, except % and values per 1 share